Human Papillomaviruses

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 05/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3166 times

66

Human Papillomaviruses

Key Points

Human papilloma viruses (HPV) comprise a large group of at least 200 genotypes of DNA viruses that infect the skin and mucosa.

Different genotypes cause different skin lesions (Table 66.1).

Clinical variants differ as to anatomic location, morphology, histopathology, and HPV subtype; correlation of clinical and histopathologic findings is particularly important for bowenoid papulosis and verrucous carcinoma in order to prevent over- or undertreatment, respectively.

Nongenital warts.

Transmitted via person-to-person contact or contact with contaminated surfaces/objects.

Prevalence of 20% in schoolchildren.

A third or more self-regress within 1–2 years.

Numerous warts or persistent/progressive warts should prompt consideration of immunosuppression, defects in cellular immunity, or other syndromes [e.g. HIV infection, epidermodysplasia verruciformis, WHIM syndrome (see Chapter 49)].

Anogenital infection with HPV.

Sexually transmitted; in young children may also be acquired perinatally or via the same routes as nongenital warts.

May be subclinical.

High-risk HPV types, especially 16 and 18, are a major cause of cervical cancer as well as cutaneous (periungual SCC) and other mucosal intraepithelial neoplasias or SCCs, in particular vaginal, vulvar, penile, and anal; HPV-associated oropharyngeal SCC is a recently identified specific subtype.

Rx.

If desired, focuses on destruction of visible lesions or induction of an immune response.

Effective targeted antiviral treatments are not available.

Prevention: prophylactic HPV vaccines (e.g. Cervarix® and Gardasil®) are available for genital warts and cervical cancer.